Antitumor agent-75
Antitumor agent-75 is a novel potent antitumor agent. Antitumor agent-75 has cytotoxic effects on cancer and normal human cell lines. Antitumor agent-75 shows a highly selective cytotoxic effect against human lung adenocarcinoma (cell line A549) when combined with Antitumor agent-74 , the IC50 value of 2.8 μM. Antitumor agent-75 can be used for the research of cancer[1].
Product Specifications
CAS Number
2827065-29-0
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antitumor-agent-75.html
Solubility
10 mM in DMSO
Smiles
CN1CCN(C2=CC=C3N=C(C4=NC5=CC=CC=C5N4)C(C6=CC=C(F)C=C6)=NC3=C2)CC1
Molecular Formula
C26H23FN6
Molecular Weight
438.50
References & Citations
[1]Vakhid A. Mamedov, et al. Synthesis of Morpholine‑, Piperidine‑, and N‑Substituted Piperazine-Coupled 2‑ (Benzimidazol-2-yl) -3-arylquinoxalines as
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Mouse Prolyl endopeptidase/PREP Protein (His Tag)
Ɑ-Mercapto-ω-Succinamic Boc Hydrazido PEG
